{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:05:30Z","timestamp":1790366730604,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:00:00Z","timestamp":1663200000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jid.2022.08.045","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T23:20:24Z","timestamp":1663284024000},"page":"294-304.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["EGFR Signaling Is Overactive in Pachyonychia Congenita: Effective Treatment with Oral Erlotinib"],"prefix":"10.1016","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6737-8126","authenticated-orcid":false,"given":"Justine","family":"Basset","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9980-6308","authenticated-orcid":false,"given":"Lucile","family":"Marchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3412-7512","authenticated-orcid":false,"given":"Alain","family":"Hovnanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2022.08.045_bib1","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ajhg.2011.12.008","article-title":"RHBDF2 mutations are associated with tylosis, a familial esophageal cancer syndrome","volume":"90","author":"Blaydon","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jid.2022.08.045_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.642820","article-title":"Modulation of pathological pain by epidermal growth factor receptor","volume":"12","author":"Borges","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jid.2022.08.045_bib3","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/bjd.16217","article-title":"Chronic pain in pachyonychia congenita: evidence for neuropathic origin","volume":"179","author":"Brill","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2022.08.045_bib4","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1093\/hmg\/ddu120","article-title":"iRHOM2-dependent regulation of ADAM17 in cutaneous disease and epidermal barrier function","volume":"23","author":"Brooke","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jid.2022.08.045_bib5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1757-1146-6-5","article-title":"A\u00a0review of the foot function index and the foot function index \u2013 revised","volume":"6","author":"Budiman-Mak","year":"2013","journal-title":"J\u00a0Foot Ankle Res"},{"key":"10.1016\/j.jid.2022.08.045_bib6","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jdermsci.2015.01.001","article-title":"Gene expression profiling in pachyonychia congenita skin","volume":"77","author":"Cao","year":"2015","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jid.2022.08.045_bib7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cell.2010.03.013","article-title":"TRP channel regulates EGFR signaling in hair morphogenesis and skin barrier formation","volume":"141","author":"Cheng","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jid.2022.08.045_bib8","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1034\/j.1600-0625.2000.009003192.x","article-title":"Cross-talk between epidermal growth factor receptor and protein kinase C during calcium-induced differentiation of keratinocytes","volume":"9","author":"Denning","year":"2000","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2022.08.045_bib9","first-page":"1283","article-title":"Keratinocyte growth factor receptor ligands induce transforming growth factor alpha expression and activate the epidermal growth factor receptor signaling pathway in cultured epidermal keratinocytes","volume":"5","author":"Dlugosz","year":"1994","journal-title":"Cell Growth Differ"},{"key":"10.1016\/j.jid.2022.08.045_bib10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13023-015-0246-5","article-title":"Olmsted syndrome: clinical, molecular and therapeutic aspects","volume":"10","author":"Duchatelet","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jid.2022.08.045_bib11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jamadermatol.2019.4126","article-title":"Use of epidermal growth factor receptor inhibitor erlotinib to treat palmoplantar keratoderma in patients with Olmsted syndrome caused by TRPV3 mutations","volume":"156","author":"Greco","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2022.08.045_bib12","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3390\/biomedicines10040841","article-title":"Treatment of painful palmoplantar keratoderma related to pachyonychia congenita using EGFR inhibitors","volume":"10","author":"Greco","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.jid.2022.08.045_bib13","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.1016\/j.jaad.2011.02.003","article-title":"An appraisal of oral retinoids in the treatment of pachyonychia congenita","volume":"66","author":"Gruber","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2022.08.045_bib14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jdermsci.2009.07.008","article-title":"Rapamycin selectively inhibits expression of an inducible keratin (K6a) in human keratinocytes and improves symptoms in pachyonychia congenita patients","volume":"56","author":"Hickerson","year":"2009","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jid.2022.08.045_bib15","doi-asserted-by":"crossref","first-page":"13727","DOI":"10.1523\/JNEUROSCI.5741-07.2008","article-title":"Overexpressed transient receptor potential vanilloid 3 ion channels in skin keratinocytes modulate pain sensitivity via prostaglandin E2 [published correction appears in J Neurosci 2009;29:29","volume":"28","author":"Huang","year":"2008","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.jid.2022.08.045_bib16","doi-asserted-by":"crossref","first-page":"6786","DOI":"10.1073\/pnas.90.14.6786","article-title":"Epidermal growth factor and transforming growth factor alpha specifically induce the activation- and hyperproliferation-associated keratins 6 and 16","volume":"90","author":"Jiang","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2022.08.045_bib17","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.yexcr.2017.09.021","article-title":"Vascular endothelial growth factor driving aberrant keratin expression pattern contributes to the pathogenesis of psoriasis","volume":"360","author":"Jiang","year":"2017","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jid.2022.08.045_bib18","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/jid.2011.44","article-title":"Toward a Treatment for Pachyonychia congenita: report on the 7th Annual International Pachyonychia Congenita Consortium Meeting","volume":"131","author":"Kaspar","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2022.08.045_bib19","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1172\/JCI84870","article-title":"Oxidative stress and dysfunctional NRF2 underlie pachyonychia congenita phenotypes","volume":"126","author":"Kerns","year":"2016","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2022.08.045_bib20","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/bja\/aev326","article-title":"Epidermal growth factor receptor-inhibition (EGFR-I) in the treatment of neuropathic pain","volume":"115","author":"Kersten","year":"2015","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jid.2022.08.045_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.sjpain.2012.11.011","article-title":"Epithelial growth factor receptor (EGFR)-inhibition for relief of neuropathic pain\u2013a case series [published correction appears in Scand J Pain 2013;4:125","volume":"4","author":"Kersten","year":"2013","journal-title":"Scand J Pain"},{"key":"10.1016\/j.jid.2022.08.045_bib22","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/wrr.12469","article-title":"Increased activity of TRPV3 in keratinocytes in hypertrophic burn scars with postburn pruritus","volume":"24","author":"Kim","year":"2016","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.jid.2022.08.045_bib23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/bjd.16700","article-title":"Plantar pain in pachyonychia congenita","volume":"179","author":"Krupiczojc","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2022.08.045_bib24","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1001\/jamadermatol.2021.5302","article-title":"Treatment of keratin 16 palmoplantar keratoderma with topical erlotinib","volume":"158","author":"Lee","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2022.08.045_bib25","doi-asserted-by":"crossref","first-page":"19537","DOI":"10.1073\/pnas.1309576110","article-title":"Keratin 16 regulates innate immunity in response to epidermal barrier breach","volume":"110","author":"Lessard","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2022.08.045_bib26","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1073\/pnas.0712397105","article-title":"Mesenchymal\u2013epithelial interactions involving epiregulin in tuberous sclerosis complex hamartomas","volume":"105","author":"Li","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2022.08.045_bib27","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nrm1014","article-title":"Transglutaminases: crosslinking enzymes with pleiotropic functions","volume":"4","author":"Lorand","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jid.2022.08.045_bib28","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00424-009-0703-x","article-title":"TRPV3 in keratinocytes transmits temperature information to sensory neurons via ATP","volume":"458","author":"Mandadi","year":"2009","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.jid.2022.08.045_bib29","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1172\/JCI87406","article-title":"Epiregulin and EGFR interactions are involved in pain processing","volume":"127","author":"Martin","year":"2017","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2022.08.045_bib30","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1097\/j.pain.0000000000000711","article-title":"Peripheral neuropathic changes in pachyonychia congenita","volume":"157","author":"Pan","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.jid.2022.08.045_bib31","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/j.pain.0000000000000092","article-title":"Selective keratinocyte stimulation is sufficient to evoke nociception in mice","volume":"156","author":"Pang","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.jid.2022.08.045_bib32","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1046\/j.1523-1747.2002.01831.x","article-title":"Functional analysis of the profilaggrin N-terminal peptide: identification of domains that regulate nuclear and cytoplasmic distribution","volume":"119","author":"Pearton","year":"2002","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2022.08.045_bib33","doi-asserted-by":"crossref","first-page":"6243","DOI":"10.1093\/nar\/gku278","article-title":"Evidence that TSC2 acts as a transcription factor and binds to and represses the promoter of epiregulin","volume":"42","author":"Pradhan","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jid.2022.08.045_bib34","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2353\/ajpath.2008.070942","article-title":"Beyond wavy hairs: the epidermal growth factor receptor and its ligands in skin biology and pathology","volume":"173","author":"Schneider","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jid.2022.08.045_bib35","series-title":"Role of TRP channels in skin diseases","first-page":"293","author":"Sulk","year":"2015"},{"key":"10.1016\/j.jid.2022.08.045_bib36","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/j.1365-2133.2010.09927.x","article-title":"Botulinum toxin in the treatment of sweat-worsened foot problems in patients with epidermolysis bullosa simplex and pachyonychia congenita","volume":"163","author":"Swartling","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2022.08.045_bib37","doi-asserted-by":"crossref","first-page":"13571","DOI":"10.1073\/pnas.202476899","article-title":"Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling","volume":"99","author":"Tee","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2022.08.045_bib38","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/ced.13686","article-title":"Novel treatment of painful plantar keratoderma in pachyonychia congenita using topical sirolimus","volume":"43","author":"Teng","year":"2018","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jid.2022.08.045_bib39","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1021\/acs.jproteome.5b00691","article-title":"Skin barrier defects caused by keratinocyte-specific deletion of ADAM17 or EGFR are based on highly similar proteome and degradome alterations","volume":"15","author":"Tholen","year":"2016","journal-title":"J\u00a0Proteome Res"},{"key":"10.1016\/j.jid.2022.08.045_bib40","doi-asserted-by":"crossref","first-page":"37285","DOI":"10.1074\/jbc.274.52.37285","article-title":"Activation of epidermal growth factor receptor promotes late terminal differentiation of cell-matrix interaction-disrupted keratinocytes","volume":"274","author":"Wakita","year":"1999","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jid.2022.08.045_bib41","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/ced.12723","article-title":"Can skin disease cause neuropathic pain? A study in pachyonychia congenita","volume":"41","author":"Wallis","year":"2016","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jid.2022.08.045_bib42","doi-asserted-by":"crossref","first-page":"45848","DOI":"10.1074\/jbc.M302630200","article-title":"Induction of disease-associated keratin 16 gene expression by epidermal growth factor is regulated through cooperation of transcription factors Sp1 and c-Jun","volume":"278","author":"Wang","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jid.2022.08.045_bib43","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/bjd.17880","article-title":"Pain mechanisms in hereditary palmoplantar keratodermas","volume":"182","author":"Weinberg","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2022.08.045_bib44","article-title":"ADAM17\/EGFR axis promotes transglutaminase-dependent skin barrier formation through phospholipase C \u03b31 and protein kinase C pathways [published correction appears in Sci Rep 2017;7:41343","volume":"6","author":"Wolf","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2022.08.045_bib45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bbrc.2006.07.213","article-title":"Expression of VEGFR-2 on HaCaT cells is regulated by VEGF and plays an active role in mediating VEGF induced effects","volume":"349","author":"Yang","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jid.2022.08.045_bib46","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1001\/jamadermatol.2019.4141","article-title":"Targeted inhibition of the epidermal growth factor receptor and mammalian target of rapamycin signaling pathways in Olmsted syndrome","volume":"156","author":"Zhang","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2022.08.045_bib47","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/bjd.18033","article-title":"Pathophysiology of pachyonychia congenita-associated palmoplantar keratoderma: new insights into skin epithelial homeostasis and avenues for treatment","volume":"182","author":"Zieman","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2022.08.045_bib48","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s004030050362","article-title":"A novel in situ method for the detection of deficient transglutaminase activity in the skin","volume":"290","author":"Raghunath","year":"1998","journal-title":"Arch Dermatol Res"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X2201898X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X2201898X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T17:30:41Z","timestamp":1758303041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X2201898X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0022202X2201898X"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2022.08.045","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EGFR Signaling Is Overactive in Pachyonychia Congenita: Effective Treatment with Oral Erlotinib","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2022.08.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}